PBRM1 mutation and preliminary response to immune checkpoint blockade treatment in NSCLC

被引：0
|
作者：
Liu, J. [1 ]
Zhou, H. [1 ]
Zhang, Y. [1 ]
Huang, Y. [1 ]
Yang, Y. [1 ]
Fang, W. [1 ]
Zhang, L. [1 ]
机构：
[1] Sun Yat Sen Univ, Canc Ctr, Dept Med Oncol, Guangzhou, Guangdong, Peoples R China
来源：
ANNALS OF ONCOLOGY | 2019年 / 30卷
基金：
国家重点研发计划;
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
320O
引用
收藏
页数：1
相关论文
共 50 条
  • [41] The role of neoantigens in response to immune checkpoint blockade
    Riaz, Nadeem
    Morris, Luc
    Havel, Jonathan J.
    Makarov, Vladimir
    Desrichard, Alexis
    Chan, Timothy A.
    INTERNATIONAL IMMUNOLOGY, 2016, 28 (08) : 411 - 419
  • [42] Genomic correlates of response to immune checkpoint blockade
    Tanya E. Keenan
    Kelly P. Burke
    Eliezer M. Van Allen
    Nature Medicine, 2019, 25 : 389 - 402
  • [43] The Puzzle of Predicting Response to Immune Checkpoint Blockade
    Onyshchenko, Mykola
    EBIOMEDICINE, 2018, 33 : 18 - 19
  • [44] DNA repair and immune checkpoint blockade response
    Guo, Jimmy A.
    Alshalalfa, Mohammed
    Kim, Daniel Y.
    Hoffman, Hannah I.
    Shiau, Carina
    Su, Jennifer
    Hwang, William L.
    Mahal, Brandon A.
    CANCER GENETICS, 2022, 264 : 1 - 4
  • [45] SETBP1 mutation determines sensitivity to immune checkpoint inhibitors in melanoma and NSCLC
    An, Fengxiao
    Zhang, Wenjing
    Guo, Yuxian
    Shi, Fuyan
    Kong, Yujia
    Tang, Liguo
    Han, Caijing
    Wang, Qinghua
    AGING-US, 2023, 15 (15): : 7476 - 7495
  • [46] Immune Checkpoint Blockade for Advanced NSCLC: A New Landscape for Elderly Patients
    Perrotta, Fabio
    Rocco, Danilo
    Vitiello, Fabiana
    De Palma, Raffaele
    Guerra, Germano
    De Luca, Antonio
    Navani, Neal
    Bianco, Andrea
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (09)
  • [47] Tumor volumetric analysis to correlate disease burden with response to dual immune checkpoint blockade in metastatic NSCLC
    Aminu, Muhammad
    Vokes, Natalie I.
    Saad, Maliazurina B.
    Li, Hui
    Hong, Lingzhi
    Mohamed, S. Mohamed
    Boom, John
    Chen, Pingjun
    Altan, Mehmet
    Gandhi, Saumil
    Swisher, Stephen
    Antonoff, Mara B.
    Pozadzides, Jenny V.
    Blumenschein, George, Jr.
    Gibbons, Don L.
    Cascone, Tina
    Elamin, Yasir Y.
    Le, Xiuning
    Negrao, Marcelo V.
    Skoulidis, Ferdinandos
    Tsao, Anne S.
    Tu, Janet
    Lee, J. Jack
    Zhang, Jianjun
    Heymach, John V.
    Wu, Jia
    CANCER RESEARCH, 2023, 83 (07)
  • [48] Immunologic Characterization of Fibrinous Pericarditis as an Immune Checkpoint Blockade Toxicity in NSCLC
    Altan, M.
    Toki, M.
    Carvajal-Hausdorf, D.
    Gettinger, S.
    Herbst, R.
    Rimm, D.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S738 - S738
  • [49] The immune landscape and response to immune checkpoint blockade therapy in lymphoma
    Kline, Justin
    Godfrey, James
    Ansell, Stephen M.
    BLOOD, 2020, 135 (08) : 523 - 533
  • [50] Radiotherapy plus immune checkpoint blockade in PD(L)-1-resistant metastatic NSCLC
    Ochoa-de-Olza, Maria
    Bourhis, Jean
    Coukos, George
    Herrera, Fernanda G.
    LANCET ONCOLOGY, 2022, 23 (04): : E157 - E157
12345